Abstract:In occidental societies, a great number of people practice sport regularly at all ages. In this context, cartilage injury incidences have become higher and higher. They are frequently diagnosed during knee arthroscopy even in asymptomatic patients. However, patients commonly present with pain, recurrent effusion, and loss of function. Concomitantly with the increasing incidence, the expectations of patients about function restore have risen as well. Since articular cartilage is characterized by a poor intrinsic regenerative capacity, treatment of these lesions is particularly challenging.Orthopedic surgeons should face this pathology not only because it is symptomatic but also for the risk of more extensive joint damage and further degeneration of the whole articular compartment.Several therapeutic strategies have been developed, both conservative and surgical. In this chapter we will focus on infiltrative therapies, such as platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and bioengineered osteochondral scaffolds.Platelet-rich plasma (PRP) is a concentrate obtained from autologous blood containing high concentrations of human platelets and platelet-derived growth factors. They are capable of modulating the early healing response and influencing inflammation, angiogenesis, and cell migration. PRP is a safe procedure, and clinical outcome is encouraging, even if it is difficult to establish PRP efficacy because authors have used different PRP formulations, with a large inter-product variability.Another powerful tool for cartilage repair emerging in recent years is mesenchymal stem cells (MSC). Their regenerative effects are due to their immunomodulatory and anti-inflammatory action but above all to their structural contribution to tissue repair. They have a capacity for self-renewal, stemness maintenance, and the marked ability to differentiate into a variety of connective tissues. MSCs can be isolated from human sources other than the bone marrow, such as adipose tissue. Studies available suggest a potential for these cell-based treatments to be developed and to represent a promising new approach with preliminary interesting findings. Nevertheless, many aspects remain to be clarified and optimized.The awareness of the involvement of the subchondral bone in many of these lesions resulted in the need to develop cell-free treatment strategies focused on the entire osteochondral unit. Therefore, surgical techniques move on from autologous chondrocyte implantation (ACI) and autograft or allograft osteochondral implantation to new bioengineered scaffolds.Ideally, a scaffold should have the following characteristics:Three-dimensional and highly porous with an interconnected pore network for cell growth and flow transport of nutrients and metabolic waste.Biocompatible and bioresorbable with a controllable degradation and resorption rate to match cell/tissue growth in vitro and/or in vivo.Suitable surface chemistry for cell attachment, proliferation, and differentiation and mechanical properties to match those of the tissues at the site of implantation.Among them MaioRegen® and, more recently, Agili-C® have shown some of the most promising results.

[Autologous minced cartilage implantation for focal cartilage lesions of the humeral capitellum]

Clinical application and research of autologous chondrocyte implant

[Bone-cartilage transfer for osteochondritis dissecans of the humeral capitellum]

Minced Autologous Chondral Fragments with Fibrin Glue as a Simple Promising One-Step Cartilage Repair Procedure: A Clinical and MRI Study at 12-Month Follow-Up

Single-Stage Arthroscopic Minced Cartilage Implantation for Focal Cartilage Defects of the Glenoid Including Glenolabral Articular Disruption Lesions: A Technical Note

Autologous platelet-rich plasma and fibrin-augmented minced cartilage implantation in chondral lesions of the knee leads to good clinical and radiological outcomes after more than 12 months: A retrospective cohort study of 71 patients

Suitability of Minced Cartilage From Osteochondral Lesions of the Talus for Immediate Autograft Reimplantation

[Technique of all arthroscopic autologous chondrocyte implantation (ACI) for the treatment of cartilage defects in the knee]

A Novel Approach for Articular Cartilage Repair in Osteoarthritis

Long-Term Clinical and MRI Results of Matrix-Assisted Autologous Chondrocyte Implantation for Articular Cartilage Defects of the Knee

Management of patellar and trochlear cartilage lesions with matrix-induced autologous chondrocyte implantation in conjunction with patellofemoral realignment procedures improves patient-reported outcomes and magnetic resonance image appearance

One-stage cartilage repair using the autologous matrix-induced chondrogenesis combined with simultaneous use of autologous adipose tissue graft and adipose tissue mesenchymal cells technique: clinical results and magnetic resonance imaging evaluation at five-year follow-up

Biological Treatment in Cartilage Injuries

One-step Articular Cartilage Repair: Combination of in Situ Bone Marrow Stem Cells with Cell-Free Poly(l-Lactic-co-glycolic Acid) Scaffold in a Rabbit Model.

Early Efficacy of Type I Collagen-Based Matrix-Assisted Autologous Chondrocyte Transplantation for the Treatment of Articular Cartilage Lesions

A hybrid repair strategy for full-thickness cartilage defects: Long-term experimental study in eight horses

Biphasic cartilage repair implant versus microfracture in the treatment of focal chondral and osteochondral lesions of the knee: a prospective, multi-center, randomized clinical trial

Hydrogel-Based Matrix-Associated Autologous Chondrocyte Implantation Shows Greater Substantial Clinical Benefit at 24 Months Follow-Up than Microfracture: A Propensity Score Matched-Pair Analysis

Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up

Comparison of Minced Cartilage Implantation with Autologous Chondrocyte Transplantation in an In Vitro Inflammation Model

Particulated Costal Allocartilage With Microfracture Versus Microfracture Alone for Knee Cartilage Defects: A Multicenter, Prospective, Randomized, Participant- and Rater-Blinded Study